Furthermore, analysis of genome-wide copy number changes and p53 immunohistochemical labeling of tissue microarrays in CAFs resected from human pancreatic cancer specimens failed to evidence somatic gene copy number losses or gain or TP53 gene mutations [43]. Here, TP53 is linked to pancreatic neoplasm.